Description
The anti-BCL9L (FVYVFTTHL) TCR Jurkat cell line is a stable cell line made from the anti-BCL9L TCR lentivirus. The recombinant Jurkat T cell was designed to predict the MOA of BCL9L-TCR, measure the BCL9L-TCR specificity and screen target cells expressing BCL9L. And the product can be used to treat cytomegalovirus infection